biote Corp. (BTMD)
NASDAQ: BTMD · Real-Time Price · USD
6.14
+0.08 (1.32%)
Nov 21, 2024, 4:00 PM EST - Market closed
biote Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 193.06 | 185.36 | 164.96 | 139.4 | 116.57 | 109.98 |
Revenue Growth (YoY) | 4.84% | 12.37% | 18.34% | 19.58% | 5.99% | - |
Cost of Revenue | 57.83 | 57.88 | 54.58 | 48.82 | 44.93 | 43.57 |
Gross Profit | 135.23 | 127.48 | 110.38 | 90.58 | 71.64 | 66.41 |
Selling, General & Admin | 95.29 | 88.74 | 145.87 | 56.02 | 39.86 | 42.88 |
Operating Expenses | 95.29 | 88.74 | 145.87 | 56.02 | 39.86 | 42.88 |
Operating Income | 39.94 | 38.75 | -35.49 | 34.56 | 31.78 | 23.53 |
Interest Expense | -9.32 | -6.36 | -4.05 | -1.67 | -2.43 | -2.08 |
Currency Exchange Gain (Loss) | - | - | 0.03 | - | - | - |
Other Non Operating Income (Expenses) | 0.45 | -13.43 | 5.6 | 0.02 | -0.01 | -0.07 |
EBT Excluding Unusual Items | 31.07 | 18.96 | -33.91 | 32.91 | 29.35 | 21.38 |
Merger & Restructuring Charges | -0.38 | -2.12 | -21.63 | - | - | - |
Legal Settlements | -5.21 | -7.97 | -3.6 | - | - | - |
Other Unusual Items | -13.92 | -8.99 | 60.86 | - | - | - |
Pretax Income | 11.57 | -0.12 | 1.71 | 32.91 | 29.35 | 21.38 |
Income Tax Expense | 2.93 | 2.68 | 0.39 | 0.29 | 0.19 | 0.09 |
Earnings From Continuing Operations | 8.64 | -2.81 | 1.32 | 32.62 | 29.16 | 21.29 |
Minority Interest in Earnings | -1.45 | 6.12 | -2.29 | - | - | - |
Net Income | 7.19 | 3.32 | -0.97 | 32.62 | 29.16 | 21.29 |
Net Income to Common | 7.19 | 3.32 | -0.97 | 32.62 | 29.16 | 21.29 |
Net Income Growth | - | - | - | 11.85% | 36.99% | - |
Shares Outstanding (Basic) | 33 | 26 | 8 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 33 | 26 | 8 | 1 | 1 | 1 |
Shares Change (YoY) | 71.05% | 219.00% | 722.55% | - | - | - |
EPS (Basic) | 0.21 | 0.13 | -0.12 | 33.29 | 29.76 | 21.73 |
EPS (Diluted) | 0.21 | 0.13 | -0.12 | 33.29 | 29.76 | 21.73 |
EPS Growth | - | - | - | 11.87% | 36.98% | - |
Free Cash Flow | 35.23 | 26.52 | -9.49 | 32.27 | 26.13 | 24.65 |
Free Cash Flow Per Share | 1.05 | 1.03 | -1.18 | 32.94 | 26.67 | 25.16 |
Gross Margin | 70.05% | 68.78% | 66.92% | 64.98% | 61.46% | 60.39% |
Operating Margin | 20.69% | 20.90% | -21.52% | 24.79% | 27.26% | 21.39% |
Profit Margin | 3.72% | 1.79% | -0.59% | 23.40% | 25.02% | 19.36% |
Free Cash Flow Margin | 18.25% | 14.31% | -5.75% | 23.15% | 22.42% | 22.41% |
EBITDA | 40.78 | 39.54 | -34.29 | 35.27 | 32.46 | 24.2 |
EBITDA Margin | 21.13% | 21.33% | -20.79% | 25.30% | 27.84% | 22.00% |
D&A For EBITDA | 0.85 | 0.79 | 1.2 | 0.71 | 0.68 | 0.67 |
EBIT | 39.94 | 38.75 | -35.49 | 34.56 | 31.78 | 23.53 |
EBIT Margin | 20.69% | 20.90% | -21.52% | 24.79% | 27.26% | 21.39% |
Effective Tax Rate | 25.32% | - | 22.66% | 0.87% | 0.64% | 0.43% |
Revenue as Reported | 193.06 | 185.36 | 164.96 | 139.4 | 116.57 | 109.98 |
Source: S&P Capital IQ. Standard template. Financial Sources.